Ownership history in UBS Group AG · 7 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in TITAN PHARMACEUTICALS INC DE (TTNP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 480 | -2,947 | -86.0% | 0.00% | $2K | — |
| 2025 Q2 | ADDED | 3,427 | +833 | +32.1% | 0.00% | $14K | — |
| 2025 Q1 | REDUCED | 2,594 | -73 | -2.7% | 0.00% | $9K | — |
| 2024 Q4 | REDUCED | 2,667 | -2,106 | -44.1% | 0.00% | $9K | — |
As of 2025 Q4 — sorted by position size